Læknaneminn - 01.04.1996, Blaðsíða 72

Breytingaskeið og hormómameðferð, seinni grein
and Gynecology Clinics of North America 1987; 14: 229-
250.
11. Ravnikar VA. Compliance with hormone therapy. Am J
Obstet Gynecol 1987; 156: 1332-1334.
12. Sidle NC. Psychological effects of different progestogens.
In: Consensus Development Conference on Progestogens
International Proceedings Journal 1989; 1: 214-217.
13. Granberg S, Wikland M, Karlsson B et al. Endometrial
thickness as measured by endovaginal ultrasonography for
identifying endometrial abnormality. Am J Obstet Gy-
necol 1991; 164: 47-52.
14. Hall G, Spector T. The use of estrogen replacement as an
adjunct therapy in rheumatoid arthritis. In: The Modern
Management of the Menopause: A perspective for the 21st
century / Eds: Berg G, Hammar M 1994; 369-375.
15. Lobo RA. Cardiovascular implications of estrogen
replacement therapy. Obstet Gynecol 1990; 75 (Suppl 4):
18-25.
16. Ross RK. Stroke prevention and oestrogen replacement
therapy. Lancet 1989; 1: 505.
17. Heaney RP. Estrogens and postmenopausal osteoporosis.
Clin Obstet Gynaecol 1976; 19: 791-803.
18. Bergkvist L, Adami HO, Persson I et al. Prognosis after
breast cancer diagnosis in women exposed to estrogen and
estrogen-progestagen replacement therapy. Am J Epidem-
iol 1989; 150: 221-228.
19. Campbell S, Whitehead MI. Oestrogen therapy and the
menopausal syndrome. Clin Obstet Gynecol 1977; 4: 31-
47.
20. Lindgren R, Berg G, Hammar M et al. Hormonal
replacement therapy and sexuality in a population of
Swedish postmenopausal women. Acta Ostet Gynecol
Scand 1993;72:292-297.
LÆKNANEMINN
64
1. tbl. 1996, 49. árg.